Interestingly, Rhein also inhibited α-smooth muscle actin (α-SMA) expression, preventing EMT, suggesting a potential therapeutic approach for DKD (Xiong et al. 2023). This evidence concerns the gene ACTA1 and diabetic kidney disease.